Lucie Cohen from 32 5Th Ave, San Mateo, CA 94402

Ikap Proteins And Methods
view source
US Patent:

61721956, Jan 9, 2001
Filed:

Apr 6, 1999
Appl. No.:

9/286891
Inventors:

Lucie Cohen - South San Francisco CA
Patrick Baeuerle - South San Francisco CA
Assignee:

Tularik Inc. - South San Francisco CA
International Classification:

C07K 100
US Classification:

530350
Abstract:

The invention provides methods and compositions relating to IKAP proteins which regulate cellular signal transduction and transcriptional activation, and related nucleic acids. The polypeptides may be produced recombinantly from transformed host cells from the disclosed IKAP encoding nucleic acids or purified from human cells. The invention provides isolated IKAP hybridization probes and primers capable of specifically hybridizing with the disclosed IKAP genes, IKAP-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceutical industry.

Ikap Nucleic Acids
view source
US Patent:

58917195, Apr 6, 1999
Filed:

Nov 16, 1997
Appl. No.:

8/971244
Inventors:

Lucie Cohen - South San Francisco CA
Patrick Baeuerle - South San Francisco CA
Assignee:

Tularik Inc. - South San Francisco CA
International Classification:

C12N 510
C12N 1512
C12N 1511
C07K 1447
US Classification:

435325
Abstract:

The invention provides methods and compositions relating to IKAP proteins which regulate cellular signal transduction and transcriptional activation, and related nucleic acids. The polypeptides may be produced recombinantly from transformed host cells from the disclosed IKAP encoding nucleic acids or purified from human cells. The invention provides isolated IKAP hybridization probes and primers capable of specifically hybridizing with the disclosed IKAP genes, IKAP-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceutical industry.